Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
Intended for Healthcare Professionals
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
  • Subscribe BJGP on YouTube
British Journal of General Practice
Intended for Healthcare Professionals

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
The Back Pages

The end of the road for the campaign against MMR

Mike Fitzpatrick
British Journal of General Practice 2007; 57 (541): 679.
Mike Fitzpatrick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info
  • eLetters
  • PDF
Loading

‘If the MMR vaccine was not the cause of my son's autism, then why has he got traces of measles virus in his bowels?’ This was the question put to me 5 years ago by one of the parents involved in the litigation against the manufacturers of the MMR vaccine. He was a passionate supporter of the campaign led by the former Royal Free researcher Andrew Wakefield who first suggested a link between MMR and autism. The claim, made in 2002 by a team led by Dublin pathologist John O‘Leary, that measles virus RNA had been detected in gut biopsies of children with autism, appeared to provide powerful vindication for Wakefield's hypothesis that a distinctive inflammatory bowel condition — dubbed ‘autistic enterocolitis’ — was the mediating link between MMR and autism.

Testimony in a US court last month by London-based molecular biologist Stephen Bustin (a world authority on PCR testing) exposed the unreliability of O'Leary's findings. Although this is good news for parents, Bustin's testimony was yet another blow for the anti-vaccine campaigners as Andrew Wakefield returns from his private clinic in Texas to face charges of professional misconduct at the General Medical Council. The hearings in the US mark the culmination of two parallel anti-vaccine campaigns. In the UK, parents of more than 1400 children were drawn into litigation against MMR, which collapsed in 2004 when the Legal Services Commission realised that, in the absence of scientific evidence, the claim had no chance of succeeding.

Meanwhile in the US, campaigners blame the mercury-based preservative thiomersal in some vaccines for the apparent increase in the prevalence of autism. The facts that the prevalence of autism has continued to rise after the removal of thiomersal from vaccines and that MMR has never contained thiomersal have not deterred campaigners from trying to link mercury and MMR in the causation of autism, through a series of speculative and improbable pathways. The court in Washington heard the first test case (of a total of 4800), that of 12-year old Michelle Cedillo whose parents believe, partly on the strength of results from O'Leary's lab, that the combination of vaccines containing thiomersal with MMR at 16 months rendered her autistic.

Unfortunately for the anti-vaccine campaigners there was no real contest — in terms of personal expertise or scientific substance — between the expert witnesses put forward in support of the vaccine-autism theory and those challenging this hypothesis. The evidence of videos revealing Michelle's autistic features long before she received MMR was particularly persuasive. In his investigation of the O‘Leary lab, Stephen Bustin discovered problems at every step of the PCR process. His conclusions were categorical: ‘the assay used was not specific for measles and it was not properly carried out.’ The positive results were positive for DNA — confirming contamination, because ‘if it's DNA it can't be measles’ (measles is an RNA virus). For Bustin it was ‘a scientific certainty’ that the O'Leary lab had failed reliably to identify measles virus RNA in Michelle or any other child. Bustin's devastating testimony effectively destroyed the only piece of positive evidence that has been produced in support of the MMR-autism thesis since it was launched nearly a decade ago.

Bustin's revelations follow a series of studies, using the most rigorous techniques, which have failed to replicate O'Leary's results, while other researchers have disputed the existence of ‘autistic enterocolitis’ as a distinctive disease entity.1–3 All these results are reassuring to parents of autistic children, whose anxieties have been needlessly provoked by the Wakefield campaign. Parents facing decisions about immunisation can also be reassured that the MMR autism scare has been shown to have no basis in science.

  • © British Journal of General Practice, 2007.

REFERENCES

  1. ↵
    1. Afzal MA
    (2006) Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK. J Med Virol 78:623–630.
    OpenUrlCrossRefPubMed
    1. D'Souza Y,
    2. Fombonne E,
    3. Ward BJ
    (2006) No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder. Pediatrics 118(4):1664–1675.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. MacDonald TT,
    2. Domizio P
    (2007) Autistic enterocolitis: is it a histopathological entity? Histopathology 50(3):371–379.
    OpenUrlCrossRefPubMed
Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 57 (541)
British Journal of General Practice
Vol. 57, Issue 541
August 2007
  • Table of Contents
  • Index by author
Download PDF
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The end of the road for the campaign against MMR
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The end of the road for the campaign against MMR
Mike Fitzpatrick
British Journal of General Practice 2007; 57 (541): 679.

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The end of the road for the campaign against MMR
Mike Fitzpatrick
British Journal of General Practice 2007; 57 (541): 679.
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • REFERENCES
  • Info
  • eLetters
  • PDF

More in this TOC Section

  • Who Is My Patient?
  • Working with vulnerable families in deprived areas
  • What is the collective noun for a group of patients?
Show more The Back Pages

Related Articles

Cited By...

Intended for Healthcare Professionals

BJGP Life

BJGP Open

 

@BJGPjournal's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2023 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242